LMAT Stock Price - LeMaitre Vascular Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch

LeMaitre Vascular, Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for LMAT for clues.

Apr. 24, 2018 at 9:03 a.m. ET
on Zacks.com

LeMaitre Vascular, Inc. (LMAT) Sees Hammer Chart Pattern: Time to Buy?

Apr. 11, 2018 at 4:53 a.m. ET
on Zacks.com

Zacks.com highlights: Stamps.com, ICU Medical, LeMaitre Vascular, United States Cellular and Everest Re Group

Apr. 2, 2018 at 7:54 a.m. ET
on Zacks.com

Boost Immunity to Market Volatility With 5 Low-Beta Stocks

We have developed a strategy which clearly shows that stocks with low risk could also reward investors with handsome returns.

Mar. 29, 2018 at 10:11 a.m. ET
on Zacks.com

Analysis Of Current Zweig Picks

Mar. 19, 2018 at 8:42 a.m. ET
on Seeking Alpha

Upcoming Dividends: 24 Companies, 8 Increases, 4 Double-Digit Increases

Mar. 15, 2018 at 7:27 a.m. ET
on Seeking Alpha

LeMaitre Vascular Inc (LMAT) Files 10-K for the Fiscal Year Ended on December 31, 2017

Mar. 9, 2018 at 12:48 p.m. ET
on GuruFocus.com

10-K: LEMAITRE VASCULAR INC

Mar. 9, 2018 at 1:09 p.m. ET
on Edgar Online - (EDG = 10Q, 10K)

LeMaitre Vascular's (LMAT) CEO George LeMaitre on Q4 2017 Results - Earnings Call Transcript

Feb. 21, 2018 at 9:44 p.m. ET
on Seeking Alpha

Notable earnings after Wednesday’s close

Feb. 20, 2018 at 5:35 p.m. ET
on Seeking Alpha

Conestoga Capital Advisors, LLC Buys Sothebys, LeMaitre Vascular Inc, The Chefs' Warehouse Inc, ...

Jan. 22, 2018 at 2:38 p.m. ET
on GuruFocus.com

LeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%)

Apr. 25, 2018 at 4:06 p.m. ET
on GlobeNewswire

LeMaitre Vascular, Inc. to Host Earnings Call

Apr. 25, 2018 at 1:03 p.m. ET
on ACCESSWIRE

LeMaitre Vascular Will Announce First Quarter 2018 Earnings Results on April 25, 2018

Apr. 18, 2018 at 4:35 p.m. ET
on GlobeNewswire

LeMaitre Vascular Divests General Surgery Product Lines

Apr. 5, 2018 at 4:50 p.m. ET
on GlobeNewswire

LeMaitre Vascular to Present at Upcoming Investor Conferences

Feb. 28, 2018 at 8:30 a.m. ET
on GlobeNewswire

LeMaitre Vascular, Inc. to Host Earnings Call

Feb. 21, 2018 at 4:21 p.m. ET
on ACCESSWIRE

LeMaitre Q4 2017 Record Sales $26.2mm (+12%), Record Op. Income $6.3mm (+62%)

Feb. 21, 2018 at 4:06 p.m. ET
on GlobeNewswire

LeMaitre Vascular Will Announce Fourth Quarter 2017 Earnings Results on February 21, 2018

Feb. 9, 2018 at 8:00 a.m. ET
on GlobeNewswire

The vascular grafts market is expected to reach USD 3.80 billion by 2022 from USD 2.67 billion in 2017, at a CAGR of 7.3%

Jan. 31, 2018 at 10:22 a.m. ET
on PR Newswire - PRF

LeMaitre Vascular to Present at the Needham Growth Conference on Thursday, January 18, 2018

Jan. 11, 2018 at 4:15 p.m. ET
on GlobeNewswire

Global vascular graft market is expected to grow with a CAGR of 5.6% over the period of 2017 - 2023

Nov. 15, 2017 at 8:54 p.m. ET
on PR Newswire - PRF

LeMaitre Vascular to Present at Upcoming November and December Investor Conferences

Nov. 1, 2017 at 4:31 p.m. ET
on GlobeNewswire

LeMaitre Q3 2017 Sales $24.8mm (+7%), Record EPS $0.25 (+49%)

Oct. 26, 2017 at 4:06 p.m. ET
on GlobeNewswire

LeMaitre Vascular, Inc. to Host Earnings Call

Oct. 26, 2017 at 12:12 p.m. ET
on ACCESSWIRE

LeMaitre Vascular Will Announce Third Quarter 2017 Earnings Results on October 26, 2017

Oct. 16, 2017 at 4:16 p.m. ET
on GlobeNewswire

LeMaitre Vascular to Present at Upcoming Investor Conferences

Sep. 5, 2017 at 4:06 p.m. ET
on GlobeNewswire

LeMaitre Vascular to Present at Upcoming Investor Conferences

Aug. 1, 2017 at 4:16 p.m. ET
on GlobeNewswire

LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%)

Jul. 27, 2017 at 4:07 p.m. ET
on GlobeNewswire

Investor Network: LeMaitre Vascular, Inc. to Host Earnings Call

Jul. 27, 2017 at 1:02 p.m. ET
on ACCESSWIRE

LeMaitre Vascular Will Announce Second Quarter 2017 Earnings Results on July 27, 2017

Jul. 13, 2017 at 4:16 p.m. ET
on GlobeNewswire

LeMaitre Vascular, Inc. is a medical device company, that engages in the provision of medical devices for the treatment of peripheral vascular disease. The company design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA. (See Full Profile)

Sell
Under
Hold
Over
Buy

Number of Ratings 6 Full Ratings

Benzinga's Top Upgrades, Downgrades For July 10, 2017

Jul. 10, 2017 at 9:28 a.m. ET
on Benzinga.com

The Benchmark Company Sees Xenotis Acquisition As Good For LeMaitre Vascular

Aug. 19, 2014 at 9:57 a.m. ET
on Benzinga.com

UPDATE: Stifel Initiates Coverage On LeMaitre Vascular On Good Investment Opportunity

Jun. 24, 2014 at 8:36 a.m. ET
on Benzinga.com

Name	Chg %	Market Cap
Endologix Inc.	0.95%	$355.26M
AngioDynamics Inc.	-0.10%	$727.63M
Cardiovascular Systems Inc.	0.75%	$755.38M
Baxter International Inc.	5.08%	$35.77B
Boston Scientific Corp.	0.12%	$40.58B

Competitor Data Provided By

Dow	24,350.89	267.06	1.11%
S&P 500	2,671.01	31.61	1.20%
Nasdaq	7,133.54	129.81	1.85%
GlobalDow	3,063.12	13.86	0.45%
Gold	1,318.50	-4.30	-0.33%
Oil	68.19	0.14	0.21%

LeMaitre Vascular Inc.

$ 32.26

Customize MarketWatch

No Items in Watchlist

No Saved Watchlists

Uh oh

No Recent Tickers

LeMaitre Vascular upgraded to buy from hold at Benchmark

LeMaitre Vascular downgraded to hold from buy at Stifel Nicolaus

LeMaitre Vascular downgraded to hold from buy at Benchmark

Lemaitre Vascular starts at neutral - Cowen & Co.

Stocks

Columns

Authors

Topics

^$ 32.26